Skip to Main Content

Paper Details

Genome-wide CRISPR/Cas9 screen identifies etoposide response modulators associated with clinical outcomes in pediatric AML.
Blood Adv
3
2023
ABCC1, AML, CRISPR, Cas9, Etoposide, PRKDC, Pediatric AML, RAD54L2, TOP2A, ZNF451, acute myeloid leukemia, cas9, children, etoposide, leukemic, leukemic cell, leukemic cell line, malignant cancers, patients
Author NameAffiliation
Christopher R CogleUniversity of Florida
Stanley PoundsSt. Jude Children's Research Hospital
Stanley PoundsSt. Jude Children's Research Hospital
  • 1 - 3

Datasets

Release 1.2